Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists zap brain to uncover secrets of walking balance

NCT ID NCT02976298

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study looked at how two brain areas—the cerebellum and the supplementary motor area—help control balance when people start walking. Twenty healthy adults received temporary magnetic pulses to briefly disrupt each brain area, and researchers measured how it affected their walking and balance. The goal was to better understand the brain's role in movement, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcranial magnetic stimulation
What this could lead to
If successful, this could improve understanding of how the brain controls balance and walking, potentially guiding future therapies for movement disorders.
What could go wrong
This is a small, early-phase study in healthy volunteers, not patients. It uses temporary brain stimulation to observe effects, not to treat any condition. Results may not translate to clinical treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

20 people

The number who actually took part.

Start date

Feb 2013

Finished

Jan 2015

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-70 years * agree to participate to the study with signature of the informed consent * heathy insurance * normal clinical exam Exclusion Criteria: * previous medical history of neurological, rheumatological, orthopedic or psychiatric disorders * contra-indication to MRI or TMS * drug treatment that modifies the nervous central system excitability (antidepressant, antiepileptic, neuroleptic) * chronic alcoholism

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Transcranial magnetic stimulation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M.L.Welter

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.